Fennec Pharmaceuticals Inc Share Price Other OTC
Equities
CA31447P1009
Biotechnology & Medical Research
Sales 2024 * | 58.64M 4.68B | Sales 2025 * | 71.15M 5.68B | Capitalization | 266M 21.27B |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.12B | Net income 2025 * | 26M 2.08B | EV / Sales 2024 * | 4.54 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.74 x |
P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
10.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.7% |
Latest transcript on Fennec Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 06/07/09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 06/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 24/04/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 24/08/11 |
Khalid Islam
CHM | Chairman | 67 | 24/04/14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 06/07/09 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |